VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European ...
Don't miss out on the headlines from AFL. Followed categories will be added to My News.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback